Mirae Asset Global Investments’s Ascendis Pharma ASND Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.04M Sell
6,023
-1,062
-15% -$183K ﹤0.01% 824
2025
Q1
$1.1M Buy
7,085
+11
+0.2% +$1.7K ﹤0.01% 796
2024
Q4
$968K Sell
7,074
-67
-0.9% -$9.16K ﹤0.01% 828
2024
Q3
$1.03M Sell
7,141
-1,075
-13% -$155K ﹤0.01% 810
2024
Q2
$1.11M Sell
8,216
-5,060
-38% -$685K 0.01% 728
2024
Q1
$1.74M Sell
13,276
-713
-5% -$93.7K ﹤0.01% 1265
2023
Q4
$1.76M Buy
13,989
+186
+1% +$23.4K ﹤0.01% 1317
2023
Q3
$1.29M Buy
13,803
+921
+7% +$86.2K ﹤0.01% 1399
2023
Q2
$1.15M Sell
12,882
-4,005
-24% -$357K ﹤0.01% 1486
2023
Q1
$1.81M Sell
16,887
-2,847
-14% -$305K ﹤0.01% 1259
2022
Q4
$2.41M Sell
19,734
-3,755
-16% -$459K 0.01% 1062
2022
Q3
$2.43M Sell
23,489
-5,995
-20% -$619K 0.01% 1059
2022
Q2
$2.74M Buy
29,484
+1,237
+4% +$115K 0.01% 1042
2022
Q1
$3.32M Sell
28,247
-1,041
-4% -$122K 0.01% 1009
2021
Q4
$3.94M Sell
29,288
-368
-1% -$49.5K 0.01% 946
2021
Q3
$4.73M Buy
29,656
+418
+1% +$66.6K 0.01% 855
2021
Q2
$3.85M Sell
29,238
-2,548
-8% -$335K 0.01% 883
2021
Q1
$4.1M Buy
31,786
+6,468
+26% +$833K 0.01% 774
2020
Q4
$4.22M Buy
25,318
+183
+0.7% +$30.5K 0.02% 693
2020
Q3
$3.88M Buy
25,135
+4,973
+25% +$767K 0.02% 602
2020
Q2
$2.98M Sell
20,162
-1,236
-6% -$183K 0.02% 609
2020
Q1
$2.41M Buy
21,398
+3,813
+22% +$429K 0.02% 593
2019
Q4
$2.45M Buy
17,585
+6,072
+53% +$845K 0.02% 690
2019
Q3
$1.11M Sell
11,513
-103
-0.9% -$9.92K 0.01% 883
2019
Q2
$1.34M Sell
11,616
-1,935
-14% -$223K 0.01% 825
2019
Q1
$1.6M Buy
13,551
+2,257
+20% +$266K 0.01% 695
2018
Q4
$708K Buy
11,294
+2,850
+34% +$179K 0.01% 882
2018
Q3
$598K Buy
8,444
+5,107
+153% +$362K ﹤0.01% 987
2018
Q2
$222K Buy
3,337
+31
+0.9% +$2.06K ﹤0.01% 743
2018
Q1
$216K Buy
+3,306
New +$216K ﹤0.01% 698